These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10049709

  • 1. Biophysical characterization of the oligomeric state of Bax and its complex formation with Bcl-XL.
    Tan YJ, Beerheide W, Ting AE.
    Biochem Biophys Res Commun; 1999 Feb 16; 255(2):334-9. PubMed ID: 10049709
    [Abstract] [Full Text] [Related]

  • 2. Acidic pH promotes dimerization of Bcl-2 family proteins.
    Xie Z, Schendel S, Matsuyama S, Reed JC.
    Biochemistry; 1998 May 05; 37(18):6410-8. PubMed ID: 9572858
    [Abstract] [Full Text] [Related]

  • 3. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
    Lindenboim L, Yuan J, Stein R.
    Oncogene; 2000 Mar 30; 19(14):1783-93. PubMed ID: 10777212
    [Abstract] [Full Text] [Related]

  • 4. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
    García-Sáez AJ, Mingarro I, Pérez-Payá E, Salgado J.
    Biochemistry; 2004 Aug 31; 43(34):10930-43. PubMed ID: 15323553
    [Abstract] [Full Text] [Related]

  • 5. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.
    Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR.
    Science; 2004 Feb 13; 303(5660):1010-4. PubMed ID: 14963330
    [Abstract] [Full Text] [Related]

  • 6. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M, Nakashima S, Banno Y, Yamakawa H, Takenaka K, Shinoda J, Nishimura Y, Sakai N, Nozawa Y.
    Oncogene; 2000 Jul 20; 19(31):3508-20. PubMed ID: 10918609
    [Abstract] [Full Text] [Related]

  • 7. The C-terminus of bax is not a membrane addressing/anchoring signal.
    Tremblais K, Oliver L, Juin P, Le Cabellec TM, Meflah K, Vallette FM.
    Biochem Biophys Res Commun; 1999 Jul 14; 260(3):582-91. PubMed ID: 10403809
    [Abstract] [Full Text] [Related]

  • 8. Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax.
    Shinoura N, Yoshida Y, Asai A, Kirino T, Hamada H.
    Oncogene; 1999 Oct 07; 18(41):5703-13. PubMed ID: 10523849
    [Abstract] [Full Text] [Related]

  • 9. Double identity for proteins of the Bcl-2 family.
    Reed JC.
    Nature; 1997 Jun 19; 387(6635):773-6. PubMed ID: 9194558
    [Abstract] [Full Text] [Related]

  • 10. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria.
    Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC.
    Biochem J; 2000 Jan 15; 345 Pt 2(Pt 2):271-8. PubMed ID: 10620504
    [Abstract] [Full Text] [Related]

  • 11. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B, Daniel PT.
    Oncogene; 2002 May 09; 21(20):3149-61. PubMed ID: 12082630
    [Abstract] [Full Text] [Related]

  • 12. Conformation of the Bax C-terminus regulates subcellular location and cell death.
    Nechushtan A, Smith CL, Hsu YT, Youle RJ.
    EMBO J; 1999 May 04; 18(9):2330-41. PubMed ID: 10228148
    [Abstract] [Full Text] [Related]

  • 13. RACK1 promotes Bax oligomerization and dissociates the interaction of Bax and Bcl-XL.
    Wu Y, Wang Y, Sun Y, Zhang L, Wang D, Ren F, Chang D, Chang Z, Jia B.
    Cell Signal; 2010 Oct 04; 22(10):1495-501. PubMed ID: 20541605
    [Abstract] [Full Text] [Related]

  • 14. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
    Zhou H, Hou Q, Chai Y, Hsu YT.
    Exp Cell Res; 2005 Oct 01; 309(2):316-28. PubMed ID: 16061221
    [Abstract] [Full Text] [Related]

  • 15. Impairment of the proapoptotic activity of Bax by missense mutations found in gastrointestinal cancers.
    Gil J, Yamamoto H, Zapata JM, Reed JC, Perucho M.
    Cancer Res; 1999 May 01; 59(9):2034-7. PubMed ID: 10232581
    [Abstract] [Full Text] [Related]

  • 16. Bax and Bcl-xL independently regulate apoptotic changes of yeast mitochondria that require VDAC but not adenine nucleotide translocator.
    Shimizu S, Shinohara Y, Tsujimoto Y.
    Oncogene; 2000 Sep 07; 19(38):4309-18. PubMed ID: 10980606
    [Abstract] [Full Text] [Related]

  • 17. Characterization of Bax-sigma, a cell death-inducing isoform of Bax.
    Schmitt E, Paquet C, Beauchemin M, Dever-Bertrand J, Bertrand R.
    Biochem Biophys Res Commun; 2000 Apr 21; 270(3):868-79. PubMed ID: 10772918
    [Abstract] [Full Text] [Related]

  • 18. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change.
    Yamaguchi H, Wang HG.
    Oncogene; 2001 Nov 22; 20(53):7779-86. PubMed ID: 11753656
    [Abstract] [Full Text] [Related]

  • 19. Impact of pH on Bax alpha conformation, oligomerisation and mitochondrial integration.
    Cartron PF, Oliver L, Mayat E, Meflah K, Vallette FM.
    FEBS Lett; 2004 Dec 03; 578(1-2):41-6. PubMed ID: 15581613
    [Abstract] [Full Text] [Related]

  • 20. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC.
    Shimizu S, Narita M, Tsujimoto Y.
    Nature; 1999 Jun 03; 399(6735):483-7. PubMed ID: 10365962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.